Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to chronic inflammation, responsible of endothelial dysfunction, oxidative stress and heightened platelet reactivity (PR). The objective of this randomised clinical trial was to test if ticagrelor is superior to clopidogrel in improving endothelial function in patients with stable coronary artery disease (SCAD) and concomitant chronic obstructive pulmonary disease (COPD). Forty-six patients with SCAD and COPD undergoing percutaneous coronary intervention (PCI) were randomly assigned to receive clopidogrel (n=23) or ticagrelor (n=23) on top of standard therapy with aspirin. The following parameters were assessed at baseline and after 1 month: i) ra...
Objectives: The study sought to assess whether treatment with ticagrelor, as compared with prasugrel...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background/Aims Coronary endothelial and microvascular function play important roles in cardiovascul...
Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to ch...
Background: Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary s...
Background-Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary sy...
Background-Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary sy...
Background Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary s...
BACKGROUND: Clopidogrel therapy has recently been shown to reduce cardiovascular events in patients ...
Ticagrelor is a powerful P2Y12inhibitor with pleiotropic effects in the cardiovascularsystem. Consis...
INTRODUCTION: Particularly in the setting of acute coronary syndromes, the interplay between vascula...
Ticagrelor is one of the most powerful P2Y12inhibitor. We have recently reported that, in patients w...
In conclusion, to our best knowledge, this is the first study to show that patients with ACS and con...
Percutaneous coronary intervention (PCI) is the most common form of revascularisation in the managem...
Abstract To investigate the effect of ticagrelor combined with tirofiban versus clopidogrel combined...
Objectives: The study sought to assess whether treatment with ticagrelor, as compared with prasugrel...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background/Aims Coronary endothelial and microvascular function play important roles in cardiovascul...
Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to ch...
Background: Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary s...
Background-Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary sy...
Background-Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary sy...
Background Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary s...
BACKGROUND: Clopidogrel therapy has recently been shown to reduce cardiovascular events in patients ...
Ticagrelor is a powerful P2Y12inhibitor with pleiotropic effects in the cardiovascularsystem. Consis...
INTRODUCTION: Particularly in the setting of acute coronary syndromes, the interplay between vascula...
Ticagrelor is one of the most powerful P2Y12inhibitor. We have recently reported that, in patients w...
In conclusion, to our best knowledge, this is the first study to show that patients with ACS and con...
Percutaneous coronary intervention (PCI) is the most common form of revascularisation in the managem...
Abstract To investigate the effect of ticagrelor combined with tirofiban versus clopidogrel combined...
Objectives: The study sought to assess whether treatment with ticagrelor, as compared with prasugrel...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background/Aims Coronary endothelial and microvascular function play important roles in cardiovascul...